Myeloproliferative diseases (CML excluded)

MYELOPROF_NONCML

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector
diagram bullet

Check conditions

not CML

355864

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
MYELOPROF_NONCML

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 1708 891 817
Unadjusted prevalence (%) 0.48 0.45 0.52
Mean age at first event (years) 61.58 60.61 62.65

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.85 [2.77, 5.35] 1.1e-15 327
15 years 0.02 2.14 [1.53, 2.99] 1.0e-5 164
5 years 0.00 2.79 [1.98, 3.93] 5.2e-9 87
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: MYELOPROF_NONCML – Myeloproliferative diseases (CML excluded)
GWS hits: 11

Survival analyses between endpoints

↥

Plot

before Myeloproliferative diseases (CML excluded)
after Myeloproliferative diseases (CML excluded)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Myeloproliferative diseases (CML excluded)

↥